Skip to main content
. 2002 Nov;8(11):1230–1238. doi: 10.3201/eid0811.020288

Table 3. Risk factors associated with clustering of multidrug-resistant tuberculosis cases, New York City, 1995–1997 (n=234).

Characteristic Clustered (n=153) No. (%) Nonclustered (n-81) No. (%) Crude OR 95% CI
Median age in yr (range) 41 (5–85) 42 (22–77) 0.99 0.98, 1.02
Male sex 93 (60.8) 49 (60.5) 1.01 0.58, 1.76
U.S.-born 120 (79.0) 42 (51.9) 3.48 1.94, 6.25
Median years of residence in United Statesb 12 (0–47) 6.5 (0–24) 1.09 1.02, 1.16
HIV serostatus
Positive 96 (62.8) 29 (35.8) 2.81 1.52, 5.22
Negative 40 (26.1) 34 (42.0) 1.00
Unknown 17 (11.1) 18 (22.2) 0.80 0.36, 1.80
Race/ethnicity
Asian 6 (3.9) 16 (19.8) 0.18 0.06, 0.53
Hispanic 49 (32.0) 24 (29.6) 1.00
Black non-Hispanic 72 (47.1) 31 (38.3) 1.14 0.60, 2.17
White non-Hispanic 26 (17.0) 10 (12.4) 1.27 0.53, 3.06
Health-care worker 12 (7.8) 2 (2.5) 3.36 0.73, 15.40
Homeless 22 (14.4) 5 (6.2) 2.55 0.92, 7.02
Injection drug usec 24 (15.7) 8 (9.9) 1.70 0.73, 3.97
Prior treatment history 10 (6.5) 12 (14.8) 0.40 0.17, 0.98
Having epidemiologic linkd
Nosocomial 7 (4.6) 0 (0) 2.97 1.02, 9.26
Community 18 (11.8) 5 (11.1)
No link 128 (83.7) 76 (88.9) 1.00
Year of diagnosis
1995 69 (45.1) 32 (39.5) 1.00
1996 54 (35.3) 27 (33.3) 0.93 0.47, 1.81
1997 30 (19.6) 22 (27.2) 0.63 0.30, 1.34

aOR, odds ratio; CI, confidence interval.
bExcludes non-U.S.-born patients. 
cInjection drug use within 12 months before diagnosis.
dCompared epidemiologic link with no epidemiologic link